Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Sutenamo 50mg Capsule
Manufacturer/Marketed By : SHIVNAAM TRADELINK LLP
$76.46 $34.07
Sutenamo 50mg Tablet consists of the active ingredient Sunitinib. It is classified as a tyrosine kinase inhibitor, which means that it works by blocking certain enzymes called tyrosine kinases that...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
SUNITINIB
Active Pharmaceutical Ingredient
Sutenamo 50mg Capsule
$76.46
$34.07
Sutenamo 50mg Tablet consists of the active ingredient Sunitinib. It is classified as a tyrosine kinase inhibitor, which means that it works by blocking certain enzymes called tyrosine kinases that are involved in the growth and spread of cancer cells. This medication is used to treat gastrointestinal stromal tumours (GIST), rare cancer that can start anywhere in the gastrointestinal tract. This medication is also used to treat advanced kidney cancer and pancreatic cancer called pancreatic neuroendocrine tumours (PNET). Cancer is a disorder in which abnormal cells grow in an uncontrolled manner. It is not recommended for people under 18. Before taking Sutenamo 50mg Tablet, it is important to discuss with the physician if you have blood conditions, heart problems, liver disorders, kidney problems, skin disorders, diabetes, seizures, or thyroid disorders. Also, inform if you have recently had surgery or are about to have surgery. Tell your doctor if you are hypertensive because this medication sometimes causes hypertension as a side effect. Avoid taking grapefruit in any form during the treatment with Sutenamo 50mg Tablet. Check with your dentist if you have any problems in the mouth, such as mouth pain, swelling, or sores inside the mouth, before starting treatment.
Active Pharmaceutical Ingredient
Uses
• Renal cell carcinoma (RCC)
• Gastrointestinal stromal tumours (GIST)
• Pancreatic neuroendocrine tumors (PNET)
• Medullary thyroid cancer
• Certain kidney cancer
Benefits
The therapeutic effects of Sutenamo 50mg Tablet include slowing down or stopping the growth and spread of cancer cells in the body, thereby reducing the size and number of tumors. It works by inhibiting the activity of specific proteins known as tyrosine kinases, which are involved in the signalling pathways that control cell growth and division. It can help to prevent cancer cells from growing and spreading by blocking these pathways.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Side effects related to Sutenamo 50mg Tablet are as follows:
Most Common Side Effects
• Fatigue
• Nausea and vomiting
• Diarrhoea
• Loss of appetite
• Hand-foot syndrome
• Skin discoloration or rash
• High blood pressure
• Headache
• Hair loss
• Changes in taste
• Dry skin or itching
• Nosebleeds
Common Side Effects
• Heart failure or heart attack
• Elevated liver function tests.
• Liver failure
• Proteinuria
• Acute kidney injury
• Interstitial lung disease (inflammation of lung walls)
• Pulmonary arterial hypertension
• Gastrointestinal perforation or fistula
• Haemorrhage (bleeding)
• Hypothyroidism (low thyroid function)
• Hypoglycemia (low blood sugar)
How To Use
Sutenamo 50mg Tablet is taken orally, in the form of capsules, with a glass of water. The capsules should be swallowed whole and not crushed, chewed, or opened. The recommended dose may vary depending on the type of cancer being treated, the patient's age and weight, and other factors. This medication is usually taken once a day, with or without food, at around the same time each day. If you miss a dose then do not double the dose to compensate for the missed dose.
Safety Advice
• Breast Feeding: It is unknown whether Sutenamo Capsule is excreted in human breast milk. Breastfeeding women should discuss the potential risks and benefits of the medication with their healthcare provider before starting treatment.
• Alcohol: It is generally recommended to avoid consuming alcohol during treatment with anticancer medication, as alcohol can potentially interfere with the effectiveness of the medication and increase liver-related and other potential side effects.
• Liver: Sutenamo 50mg Tablet can cause liver toxicity, which can be severe or fatal in some cases. Patients taking this medication should be done their liver function tests regularly, and treatment should be interrupted or discontinued if these tests are abnormal.
• Lungs: Sutenamo 50mg Tablet can cause interstitial lung disease (ILD), a serious and potentially fatal condition that causes scarring of the lungs. Patients taking this medication should be monitored for symptoms of ILD, such as cough, shortness of breath, and fever, and treatment should be interrupted or discontinued if necessary.
• Driving: Patients receiving Sutenamo 50mg Tablet are advised to avoid driving or operating machinery if they experience side effects such as fatigue, dizziness, or blurred vision, impairing a patient's ability to drive or operate machinery safely.
• Pregnancy: Sutenamo 50mg Tablet is unsafe for a developing fetus and is not recommended during pregnancy as it can cause harm to the developing fetus.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.